Modification of the lipidic and coagulative pattern in postmenopause women

Effect of hormone replacement therapy

G. Evola, G. Novo, G. Amoroso, D. Guttilla, L. Lo Coco, M. Guagliardo, A. Lupo, M. R. Averna, V. Giambanco, Virginia M Miller, S. Novo

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Aim. We evaluated the changes of lipidic and coagulative pattern during menopause and the influence of hormone replacement therapy (HRT) on these parameters. Methods. We considered 158 patients divided into 2 groups: Group I consisted of 127 women in physiological/surgical menopause and Group II of 31 women with childbearing potential. Subsequently, we considered a group III formed of 34 patients from menopausal women (group I) who underwent three months of HRT. We evaluated total-cholesterol (TC), HDL-cholesterol (HDL-C), LDL-cholesterol (LDL-C), triglycerides (TG), lipoprotein (a) (Lpa), fibrinogen, antithrombin III (ATIII), factor VII (FVII) and tissue factor pathway inhibitor (TFPI). Results. We found a worse lipid profile in the postmenopausal group compared to controls (TC 243.8±29.7 vs 217.9±32.7 mg%, P=0.002; TG 121.5±68.4 vs 88.6±53.0 mg%, P=0.039; LDL-C 163.0±27.9 vs 136.2±29.6 mg%, P=0.004; HDL-C 60.9±14.9 vs 64.1±14.6 mg%, P=ns). With regard to the coagulative pattern, fibrinogen was significantly higher in the post-menopausal group (fibrinogen: 273.3±67.4 vs 243.8±39.5 mg%, P=0.013; ATIII 112.2±11.7 vs 117.5±12.7% %, P=0.059; FVII 121.6*11.3 vs 117.6±10.8 mg%, P=ns; TFPI activity 2.5±2.3 vs 2.1±1.1 V/mL, P=ns; TFPI antigen 120±38 vs 127±39 U/mL, P=ns). Comparing the same parameters, before and after three months of HRT, in patients of Group III we observed a significant improvement of TC and TG levels (TC from 232.3±42.7 to 215.2±37.6 mg%, P=0.0001; TG from 103.7±56.8 to 95.0±44.3 mg%, P=0.059; HDL-C from 62.3±12.9 to 63.6±12.6 mg%, P=ns; LDL-C from 149.3±38.7 to 132.6±34.5 mg%, P=0.0001). The following changes were observed with regard to coagulative parameters: fibrinogen from 270.9±69.4 to 253.2±56.2 mg%, P=0.07; ATIII from 113.5±11.4 to 110.8±13.2 mg%, P=0.198; FVII from 108.6±18.0 to 104.4±17.5 mg%, 0.014. TFPI activity from 2.6*2.3 to 2.3*1.4 U/ml, P=ns; TFPI antigen from 68*13 to 87*22 U/mL, P=0.001. Conclusions. Our data confirm the presence of an alteration in lipidic and coagulative pattern in post menopausal women and positive changes after HRT.

Original languageEnglish (US)
Pages (from-to)355-361
Number of pages7
JournalInternational Angiology
Volume29
Issue number4
StatePublished - Aug 2010

Fingerprint

Postmenopause
Hormone Replacement Therapy
Fibrinogen
Factor VII
Antithrombin III
Cholesterol
LDL Cholesterol
HDL Cholesterol
Triglycerides
Menopause
Antigens
Lipoprotein(a)
lipoprotein-associated coagulation inhibitor
Lipids

Keywords

  • Hormone replacement therapy
  • Menopause
  • Tissue factor pathway inhibitor

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Evola, G., Novo, G., Amoroso, G., Guttilla, D., Lo Coco, L., Guagliardo, M., ... Novo, S. (2010). Modification of the lipidic and coagulative pattern in postmenopause women: Effect of hormone replacement therapy. International Angiology, 29(4), 355-361.

Modification of the lipidic and coagulative pattern in postmenopause women : Effect of hormone replacement therapy. / Evola, G.; Novo, G.; Amoroso, G.; Guttilla, D.; Lo Coco, L.; Guagliardo, M.; Lupo, A.; Averna, M. R.; Giambanco, V.; Miller, Virginia M; Novo, S.

In: International Angiology, Vol. 29, No. 4, 08.2010, p. 355-361.

Research output: Contribution to journalArticle

Evola, G, Novo, G, Amoroso, G, Guttilla, D, Lo Coco, L, Guagliardo, M, Lupo, A, Averna, MR, Giambanco, V, Miller, VM & Novo, S 2010, 'Modification of the lipidic and coagulative pattern in postmenopause women: Effect of hormone replacement therapy', International Angiology, vol. 29, no. 4, pp. 355-361.
Evola G, Novo G, Amoroso G, Guttilla D, Lo Coco L, Guagliardo M et al. Modification of the lipidic and coagulative pattern in postmenopause women: Effect of hormone replacement therapy. International Angiology. 2010 Aug;29(4):355-361.
Evola, G. ; Novo, G. ; Amoroso, G. ; Guttilla, D. ; Lo Coco, L. ; Guagliardo, M. ; Lupo, A. ; Averna, M. R. ; Giambanco, V. ; Miller, Virginia M ; Novo, S. / Modification of the lipidic and coagulative pattern in postmenopause women : Effect of hormone replacement therapy. In: International Angiology. 2010 ; Vol. 29, No. 4. pp. 355-361.
@article{989d1df93f2b405b8694c7125d5093a8,
title = "Modification of the lipidic and coagulative pattern in postmenopause women: Effect of hormone replacement therapy",
abstract = "Aim. We evaluated the changes of lipidic and coagulative pattern during menopause and the influence of hormone replacement therapy (HRT) on these parameters. Methods. We considered 158 patients divided into 2 groups: Group I consisted of 127 women in physiological/surgical menopause and Group II of 31 women with childbearing potential. Subsequently, we considered a group III formed of 34 patients from menopausal women (group I) who underwent three months of HRT. We evaluated total-cholesterol (TC), HDL-cholesterol (HDL-C), LDL-cholesterol (LDL-C), triglycerides (TG), lipoprotein (a) (Lpa), fibrinogen, antithrombin III (ATIII), factor VII (FVII) and tissue factor pathway inhibitor (TFPI). Results. We found a worse lipid profile in the postmenopausal group compared to controls (TC 243.8±29.7 vs 217.9±32.7 mg{\%}, P=0.002; TG 121.5±68.4 vs 88.6±53.0 mg{\%}, P=0.039; LDL-C 163.0±27.9 vs 136.2±29.6 mg{\%}, P=0.004; HDL-C 60.9±14.9 vs 64.1±14.6 mg{\%}, P=ns). With regard to the coagulative pattern, fibrinogen was significantly higher in the post-menopausal group (fibrinogen: 273.3±67.4 vs 243.8±39.5 mg{\%}, P=0.013; ATIII 112.2±11.7 vs 117.5±12.7{\%} {\%}, P=0.059; FVII 121.6*11.3 vs 117.6±10.8 mg{\%}, P=ns; TFPI activity 2.5±2.3 vs 2.1±1.1 V/mL, P=ns; TFPI antigen 120±38 vs 127±39 U/mL, P=ns). Comparing the same parameters, before and after three months of HRT, in patients of Group III we observed a significant improvement of TC and TG levels (TC from 232.3±42.7 to 215.2±37.6 mg{\%}, P=0.0001; TG from 103.7±56.8 to 95.0±44.3 mg{\%}, P=0.059; HDL-C from 62.3±12.9 to 63.6±12.6 mg{\%}, P=ns; LDL-C from 149.3±38.7 to 132.6±34.5 mg{\%}, P=0.0001). The following changes were observed with regard to coagulative parameters: fibrinogen from 270.9±69.4 to 253.2±56.2 mg{\%}, P=0.07; ATIII from 113.5±11.4 to 110.8±13.2 mg{\%}, P=0.198; FVII from 108.6±18.0 to 104.4±17.5 mg{\%}, 0.014. TFPI activity from 2.6*2.3 to 2.3*1.4 U/ml, P=ns; TFPI antigen from 68*13 to 87*22 U/mL, P=0.001. Conclusions. Our data confirm the presence of an alteration in lipidic and coagulative pattern in post menopausal women and positive changes after HRT.",
keywords = "Hormone replacement therapy, Menopause, Tissue factor pathway inhibitor",
author = "G. Evola and G. Novo and G. Amoroso and D. Guttilla and {Lo Coco}, L. and M. Guagliardo and A. Lupo and Averna, {M. R.} and V. Giambanco and Miller, {Virginia M} and S. Novo",
year = "2010",
month = "8",
language = "English (US)",
volume = "29",
pages = "355--361",
journal = "International Angiology",
issn = "0392-9590",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "4",

}

TY - JOUR

T1 - Modification of the lipidic and coagulative pattern in postmenopause women

T2 - Effect of hormone replacement therapy

AU - Evola, G.

AU - Novo, G.

AU - Amoroso, G.

AU - Guttilla, D.

AU - Lo Coco, L.

AU - Guagliardo, M.

AU - Lupo, A.

AU - Averna, M. R.

AU - Giambanco, V.

AU - Miller, Virginia M

AU - Novo, S.

PY - 2010/8

Y1 - 2010/8

N2 - Aim. We evaluated the changes of lipidic and coagulative pattern during menopause and the influence of hormone replacement therapy (HRT) on these parameters. Methods. We considered 158 patients divided into 2 groups: Group I consisted of 127 women in physiological/surgical menopause and Group II of 31 women with childbearing potential. Subsequently, we considered a group III formed of 34 patients from menopausal women (group I) who underwent three months of HRT. We evaluated total-cholesterol (TC), HDL-cholesterol (HDL-C), LDL-cholesterol (LDL-C), triglycerides (TG), lipoprotein (a) (Lpa), fibrinogen, antithrombin III (ATIII), factor VII (FVII) and tissue factor pathway inhibitor (TFPI). Results. We found a worse lipid profile in the postmenopausal group compared to controls (TC 243.8±29.7 vs 217.9±32.7 mg%, P=0.002; TG 121.5±68.4 vs 88.6±53.0 mg%, P=0.039; LDL-C 163.0±27.9 vs 136.2±29.6 mg%, P=0.004; HDL-C 60.9±14.9 vs 64.1±14.6 mg%, P=ns). With regard to the coagulative pattern, fibrinogen was significantly higher in the post-menopausal group (fibrinogen: 273.3±67.4 vs 243.8±39.5 mg%, P=0.013; ATIII 112.2±11.7 vs 117.5±12.7% %, P=0.059; FVII 121.6*11.3 vs 117.6±10.8 mg%, P=ns; TFPI activity 2.5±2.3 vs 2.1±1.1 V/mL, P=ns; TFPI antigen 120±38 vs 127±39 U/mL, P=ns). Comparing the same parameters, before and after three months of HRT, in patients of Group III we observed a significant improvement of TC and TG levels (TC from 232.3±42.7 to 215.2±37.6 mg%, P=0.0001; TG from 103.7±56.8 to 95.0±44.3 mg%, P=0.059; HDL-C from 62.3±12.9 to 63.6±12.6 mg%, P=ns; LDL-C from 149.3±38.7 to 132.6±34.5 mg%, P=0.0001). The following changes were observed with regard to coagulative parameters: fibrinogen from 270.9±69.4 to 253.2±56.2 mg%, P=0.07; ATIII from 113.5±11.4 to 110.8±13.2 mg%, P=0.198; FVII from 108.6±18.0 to 104.4±17.5 mg%, 0.014. TFPI activity from 2.6*2.3 to 2.3*1.4 U/ml, P=ns; TFPI antigen from 68*13 to 87*22 U/mL, P=0.001. Conclusions. Our data confirm the presence of an alteration in lipidic and coagulative pattern in post menopausal women and positive changes after HRT.

AB - Aim. We evaluated the changes of lipidic and coagulative pattern during menopause and the influence of hormone replacement therapy (HRT) on these parameters. Methods. We considered 158 patients divided into 2 groups: Group I consisted of 127 women in physiological/surgical menopause and Group II of 31 women with childbearing potential. Subsequently, we considered a group III formed of 34 patients from menopausal women (group I) who underwent three months of HRT. We evaluated total-cholesterol (TC), HDL-cholesterol (HDL-C), LDL-cholesterol (LDL-C), triglycerides (TG), lipoprotein (a) (Lpa), fibrinogen, antithrombin III (ATIII), factor VII (FVII) and tissue factor pathway inhibitor (TFPI). Results. We found a worse lipid profile in the postmenopausal group compared to controls (TC 243.8±29.7 vs 217.9±32.7 mg%, P=0.002; TG 121.5±68.4 vs 88.6±53.0 mg%, P=0.039; LDL-C 163.0±27.9 vs 136.2±29.6 mg%, P=0.004; HDL-C 60.9±14.9 vs 64.1±14.6 mg%, P=ns). With regard to the coagulative pattern, fibrinogen was significantly higher in the post-menopausal group (fibrinogen: 273.3±67.4 vs 243.8±39.5 mg%, P=0.013; ATIII 112.2±11.7 vs 117.5±12.7% %, P=0.059; FVII 121.6*11.3 vs 117.6±10.8 mg%, P=ns; TFPI activity 2.5±2.3 vs 2.1±1.1 V/mL, P=ns; TFPI antigen 120±38 vs 127±39 U/mL, P=ns). Comparing the same parameters, before and after three months of HRT, in patients of Group III we observed a significant improvement of TC and TG levels (TC from 232.3±42.7 to 215.2±37.6 mg%, P=0.0001; TG from 103.7±56.8 to 95.0±44.3 mg%, P=0.059; HDL-C from 62.3±12.9 to 63.6±12.6 mg%, P=ns; LDL-C from 149.3±38.7 to 132.6±34.5 mg%, P=0.0001). The following changes were observed with regard to coagulative parameters: fibrinogen from 270.9±69.4 to 253.2±56.2 mg%, P=0.07; ATIII from 113.5±11.4 to 110.8±13.2 mg%, P=0.198; FVII from 108.6±18.0 to 104.4±17.5 mg%, 0.014. TFPI activity from 2.6*2.3 to 2.3*1.4 U/ml, P=ns; TFPI antigen from 68*13 to 87*22 U/mL, P=0.001. Conclusions. Our data confirm the presence of an alteration in lipidic and coagulative pattern in post menopausal women and positive changes after HRT.

KW - Hormone replacement therapy

KW - Menopause

KW - Tissue factor pathway inhibitor

UR - http://www.scopus.com/inward/record.url?scp=77958600636&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77958600636&partnerID=8YFLogxK

M3 - Article

VL - 29

SP - 355

EP - 361

JO - International Angiology

JF - International Angiology

SN - 0392-9590

IS - 4

ER -